Revexepride

CAS No. 219984-49-3

Revexepride ( SSP 002358;SPD-557 )

Catalog No. M13507 CAS No. 219984-49-3

Revexepride (SSP 002358;SPD-557) potent, highly selective 5-HT4 receptor agonist for the treatment of gastroesophageal reflux disease.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1251 Get Quote
50MG 2862 Get Quote
100MG 3870 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Revexepride
  • Note
    Research use only, not for human use.
  • Brief Description
    Revexepride (SSP 002358;SPD-557) potent, highly selective 5-HT4 receptor agonist for the treatment of gastroesophageal reflux disease.
  • Description
    Revexepride (SSP 002358;SPD-557) potent, highly selective 5-HT4 receptor agonist for the treatment of gastroesophageal reflux disease. Other Indication Phase 2 Discontinued
  • Synonyms
    SSP 002358;SPD-557
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    5-HT Receptor
  • Research Area
    Other Indications
  • Indication
    Other Disease

Chemical Information

  • CAS Number
    219984-49-3
  • Formula Weight
    425.95
  • Molecular Formula
    C21H32ClN3O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(C1=CC(Cl)=C(N)C2=C1OC(C)(C)C2)NC[C@H]3[C@H](O)CN(CCCOC)CC3
  • Chemical Name
    4-amino-5-chloro-N-(((3S,4S)-3-hydroxy-1-(3-methoxypropyl)piperidin-4-yl)methyl)-2,2-dimethyl-2,3-dihydrobenzofuran-7-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Flach S, et al. Drug Des Devel Ther. 2016 Sep 27;10:3125-3132.
2. Shaheen NJ, et al. Aliment Pharmacol Ther. 2015 Apr;41(7):649-61.
molnova catalog
related products
  • EMD-281014

    EMD-281014 (Pruvanserin, LSN2411347, LY-2422347) is a potent, highly selective 5-HT2A antagonist with Ki of 0.87 nM.

  • CP-809101 hydrochlor...

    CP-809101 hydrochloride is a potent and selective 5-HT2C receptor agonist (pEC50: 9.96/7.19/6.81 for human 5-HT2C/5-HT2B/5-HT2A receptors).

  • Astragaloside

    Astragaloside IV, an active component isolated from Astragalus membranaceus, suppresses the activation of ERK1/2 and JNK, and downregulates matrix metalloproteases (MMP)-2, (MMP)-9 in MDA-MB-231 breast cancer cells.